Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
(NASDAQ: QNRX) Delayed: 4.41 -0.24 (5.16%)
Previous Close $4.65    52 Week High $ 
Open $4.56    52 Week Low $ 
Day High $4.83    P/E N/A 
Day Low $4.41    EPS $ 
Volume 15,647